Skip to main content
OpenTrials

Clinical trial condition

Gastro-enteropancreatic Neuroendocrine Tumor

Explore clinical trials studying Gastro-enteropancreatic Neuroendocrine Tumor. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Gastro-enteropancreatic Neuroendocrine Tumor trial results

Active, not recruiting

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET

NCT05050942

Conditions
Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor
Locations
  • Mayo Clinic Cancer Center (MCCC) - Phoenix Phoenix, Arizona, United States
  • UCLA Ahmanson Biological Imaging Center Santa Monica, California, United States
  • Rocky Mountain Cancer Centers - Denver - Midtown Denver, Colorado, United States
  • Mayo Clinic Hospital - Florida Jacksonville, Florida, United States
View all 86 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET

NCT03972488

Conditions
Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • USF - H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Iowa Hospitals and Clinics - Oncology Iowa City, Iowa, United States
  • University of Kentucky UK Markey Cancer Center Lexington, Kentucky, United States
View all 40 locations
View Trial Details
Active, not recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

NCT03600233

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
Locations
  • Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Completed

A Study of Peptide Receptor Radionuclide Therapy (PRRT) Use in Neuroendocrine Tumor (NET) Patients in Germany

NCT07653126

Conditions
Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, +5 more
Locations
  • Novartis Investigative Site Essen, Germany
  • Novartis Investigative Site Heidelberg, Germany
  • Novartis Investigative Site München, Germany
  • Novartis Investigative Site Rostock, Germany
View Trial Details
Completed

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

NCT03220217

Conditions
Gastro-enteropancreatic Neuroendocrine Tumor, Gastro-enteropancreatic neuroendocrine tumor
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Medical University of Innsbruck Innsbruck, Austria
  • University Clinic for Radiology and Nuclear Medicine Vienna, Austria
  • Aarhus University Hospital Aarhus, Denmark
View Trial Details

Related conditions